Tick-Borne Encephalitis is a viral disease that attacks the central nervous system and can result in serious illness and even death. Tick-Borne Encephalitis is endemic in the regions of at least 27 European countries and well as parts of Asia. TicoVac® is a licensed product in the UK and Europe, it is now available in Australia and can be supplied under The Special Access Scheme (SAS Catergory B)
http://www.health.gov.au/internet/immunise/publishing.nsf/Content/handbook10-3-2
Please contact us for further information contact@hlpharma.com.au or telephone 03 9823 6228
